APA-referens (7:e uppl.)

Jung, J., Park, H., Park, C., Cho, S., Choi, I. S., Moon, H., . . . Choi, B. W. (2021). Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma. The Korean Journal of Internal Medicine, 36(4), 1001-1013. https://doi.org/10.3904/kjim.2020.549

Chicago-referens (17:e uppl.)

Jung, Jae-Woo, et al. "Effect of Omalizumab as Add-on Therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean Patients with Severe Persistent Allergic Asthma." The Korean Journal of Internal Medicine 36, no. 4 (2021): 1001-1013. https://doi.org/10.3904/kjim.2020.549.

MLA-referens (9:e uppl.)

Jung, Jae-Woo, et al. "Effect of Omalizumab as Add-on Therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean Patients with Severe Persistent Allergic Asthma." The Korean Journal of Internal Medicine, vol. 36, no. 4, 2021, pp. 1001-1013, https://doi.org/10.3904/kjim.2020.549.

Varning: dessa hänvisningar är inte alltid fullständigt riktiga.